Literatur
Yusuf S, Pepine CJ, Garces C et al (1992) Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 340:1173–1178
Viberti G, Mogensen CE, Groop LC, Pauls JF, European Microalbuminuria Captopril Study Group (1994) Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271:275–279
American Diabetes Association (2015) Standards of medical care in diabetes–2015: summary of revisions. Diabetes Care 38(Suppl 1):S4
Weber MA, Schiffrin EL, White WB et al (2014) Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 32:3–15
Mancia G, Fagard R, Narkiewicz K et al (2013) Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:1281–1357
James PA, Oparil S, Carter BL et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:507–520
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Jecht gibt an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Jecht, M. Renin-Angiotensin-System-Blocker bei Diabetes mellitus. Diabetologe 12, 203–204 (2016). https://doi.org/10.1007/s11428-016-0087-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-016-0087-4